Ohr Pharmaceutical Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Ohr Pharmaceutical Inc
CIK #0001173281
EDGAR Form CIK 2011 - 2025
10-K [0001173281]
10-Q [0001173281]
3 [0001173281]
4 [0001173281]
5 [0001173281]
8-K [0001173281]
D [0001173281]
SC 13D [0001173281]
SC 13G [0001173281]
Form 13D/13G Filer Form 13D/13G Subject Filed
Symetryx Corp Neubase Therapeutics Inc [2023-08-31]
Titcomb Shawn Neubase Therapeutics Inc [2019-08-27]
Thadke Shivaji Neubase Therapeutics Inc [2019-07-22]
Stephan Dietrich A Neubase Therapeutics Inc [2019-07-22]
Carnegie Mellon University Neubase Therapeutics Inc [2019-07-22]
Kershner Trading Americas LLC Neubase Therapeutics Inc [2019-07-18]
Greenlight Capital Inc Neubase Therapeutics Inc [2019-07-16]
Slakter Jason Scott OHR Pharmaceutical Inc [2016-01-29]
Broadfin Capital LLC OHR Pharmaceutical Inc [2015-04-07]
Visium Asset Management LP OHR Pharmaceutical Inc [2014-07-11]
View All
Form 3/4/5 Subject 2011 - 2025
Shiff Aleta
Shiff Barry
Symetryx Corp
NeuBase Therapeutics, Inc.
Stephan Dietrich A
Branning Todd P.
Richman Eric I
Prendergast Franklyn G
McDougall Gerald J
Goldstein Dov A MD
View All
Terms | Privacy | Guide
tony@aum13f.com